Theratechnologies Statistics Share Statistics Theratechnologies has 45.98M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 45.98M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 25.87% Shares Floating 36.33M Failed to Deliver (FTD) Shares 1,093 FTD / Avg. Volume 0.23%
Short Selling Information The latest short interest is 310.49K, so 0.68% of the outstanding
shares have been sold short.
Short Interest 310.49K Short % of Shares Out 0.68% Short % of Float 0.99% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -7.19 and the forward
PE ratio is 22.82.
Theratechnologies's PEG ratio is
0.15.
PE Ratio -7.19 Forward PE 22.82 PS Ratio 0.7 Forward PS 1.6 PB Ratio -2.36 P/FCF Ratio 67.95 PEG Ratio 0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Theratechnologies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.19,
with a Debt / Equity ratio of -1.8.
Current Ratio 1.19 Quick Ratio 1.05 Debt / Equity -1.8 Debt / EBITDA 6.63 Debt / FCF 51.88 Interest Coverage 0.78
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $833.65K Profits Per Employee $-80.64K Employee Count 103 Asset Turnover 1.61 Inventory Turnover 3.87
Taxes Income Tax 2M Effective Tax Rate -31.82%
Stock Price Statistics The stock price has increased by 138.81% in the
last 52 weeks. The beta is 0.83, so Theratechnologies's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change 138.81% 50-Day Moving Average 2.84 200-Day Moving Average 2.04 Relative Strength Index (RSI) 72.2 Average Volume (20 Days) 473,404
Income Statement In the last 12 months, Theratechnologies had revenue of 85.87M
and earned -8.31M
in profits. Earnings per share was -0.17.
Revenue 85.87M Gross Profit 65.42M Operating Income 8.17M Net Income -8.31M EBITDA 6.88M EBIT 4.12M Earnings Per Share (EPS) -0.17
Full Income Statement Balance Sheet The company has 5.9M in cash and 45.61M in
debt, giving a net cash position of -39.71M.
Cash & Cash Equivalents 5.9M Total Debt 45.61M Net Cash -39.71M Retained Earnings -416.89M Total Assets 51.27M Working Capital -6.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 2.38M
and capital expenditures -1.5M, giving a free cash flow of 879K.
Operating Cash Flow 2.38M Capital Expenditures -1.5M Free Cash Flow 879K FCF Per Share 0.02
Full Cash Flow Statement Margins Gross margin is 76.19%, with operating and profit margins of 9.52% and -9.67%.
Gross Margin 76.19% Operating Margin 9.52% Pretax Margin -7.34% Profit Margin -9.67% EBITDA Margin 8.01% EBIT Margin 9.52% FCF Margin 1.02%
Dividends & Yields THTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for THTX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 31, 2023. It was a
backward
split with a ratio of 1:4.
Last Split Date Jul 31, 2023 Split Type backward Split Ratio 1:4
Scores Altman Z-Score -8.87 Piotroski F-Score 5
